EY R&D Workbench for Pharma

In Life Sciences

The EY R&D Workbench for Pharma is a unique tech solution for effective project planning management, workflow and issue and query tracking in the R&D environment. It leads to improved market speed and increased transparency and accountability throughout various organizations involved in formulation (across multiple dosage forms), API and biosimilar.

Request a demo

What EY can do for you

In the pharma sector, R&D processes are often siloed, leading to suboptimal outcomes. Roles and responsibilities are not clearly defined, leading to slow down in the growth of organization. EY R&D Workbench provides a holistic solution to transform the R&D ecosystem by providing opportunities like:

EY R&D Workbench has successfully resolved critical issues of the pharma sector, leading to efficient processes and tangible impact. 

EY R&D Workbench is a one-stop cross-departmental collaborative platform to monitor and keep pace with the dynamically transforming R&D environment with enhanced transparency and accountability throughout the organization.

Key features:

Andrew Mosker

Project management capabilities

  • Basic project management functionality
  • Re-baselining with version history and change management
  • Timesheet module for effective utilization
  • Admin modules and user management 


Andrew Mosker

Functional capabilities

  • Portfolio evaluation and management
  • Product selection, technical evaluation, complexity assessment, commercial evaluation and PIF as a part of portfolio evaluation and product selection modules
  • Predictive risk assessment
  • Issue tracker
  • Deficiency tracking mechanism
  • Integration with other tools, such as SAP, LIMS, ELN, etc.
  • Digitized and automated notification and escalations 


Andrew Mosker

Leadership dashboards

  • Customized dashboards and landing pages (role wise)
  • Customized actionable dashboard for ongoing and upcoming task completion updates and status visibility 


Andrew Mosker

User report and dashboards

  • Customized reports (Query search, summary and analytics, Budget, Project summary, Project pipeline, Time tracking, Project milestone, Efficiency, MIS)
  • Detailed forms and complex workflows for SLA change, rebaseling, approvals and send back requests in portfolio evaluation and product selection modules
  • Customized project templates for various dosage forms


Why EY

R&D has been a key focus area for most Indian pharma companies. Though India is a leader in terms of ANDA approvals globally, there is a significant scope for improving the same to achieve faster launches. We have been working with leading pharma companies to transform their R&D organizations. As a part of the transformation program, we have delivered a reduction in end-to-end timelines (Initiation to Launch) of ~15 to 20%, improving FTR (First Time Right) to >85% across R&D processes. We look at R&D from an enterprise-wide perspective, including critical elements of people, process, and technology. The typical transformation journey kicks off by re-designing the organization structure to support the agreed to-be processes. Once the same is implemented, the processes are enabled with an EY proprietary tool called “R&D Workbench for Pharma.” It is a unique solution, led by experienced professionals with strong global experience of working in R&D technology enablement programs and change management. EY has empowered organizations with several such fit-for-purpose tech platforms and tools, boosting their end-to-end process capabilities.

Direct to your inbox

Stay up to date with our Editor's picks newsletter. 


Contact us

Like what you’ve seen? Get in touch to learn more.